Benzodiazepine Drugs Market Size, Share, Trends, Growth Outlook

The Global Benzodiazepine Drugs Market Size is estimated to register 3.2% growth over the forecast period from 2024 to 2030.

 

The market growth is driven by increasing pharmaceutical companies are continually exploring and developing new formulations and delivery methods for benzodiazepine drugs. This includes extended-release formulations, sublingual tablets, and transdermal patches. Technological advancements in drug delivery aim to improve efficacy, reduce side effects, and enhance patient compliance, contributing to the overall growth and innovation in the benzodiazepine drugs market. Leading Companies focusing on Personalized Medicine Approaches, Novel Drug Combinations and Formulations, Digital Health Integration for Monitoring and Support, and others to boost market shares in the industry.

 

Market Overview

The benzodiazepine drugs market encompasses pharmaceuticals with sedative and anxiolytic properties, commonly prescribed for conditions like anxiety, insomnia, and seizures. Key drivers include the increasing prevalence of anxiety disorders and the aging population. Challenges involve concerns about over-dependence and abuse, regulatory scrutiny, and generic competition. Trends include rising prescription rates in primary care and heightened awareness of post-traumatic stress disorder. The future scope may involve personalized medicine, novel formulations, and digital health integration. Regulatory bodies oversee drug approval and safety. Major pharmaceutical players invest in research and development to maintain market share. The market is dynamic, influenced by ongoing research and regulatory changes. For the latest information, consult recent market reports and industry updates.

 

Market Dynamics

Market Trends- Increased anxiety levels in demographics like millennials and the elderly are fueling the demand for benzodiazepine drugs.

The growing demand for benzodiazepine drugs stems from an increase in anxiety levels, notably among demographics such as millennials and the elderly. Millennials, confronting distinct socio-economic challenges, are grappling with heightened stress and anxiety attributed to factors like economic uncertainties, job pressures, and the pervasive impact of digital technology. Similarly, the elderly population, contending with age-related concerns, may experience anxiety linked to health issues, social isolation, and life transitions. The ready availability of benzodiazepines, known for their rapid anxiety-alleviating effects, positions them as sought-after solutions for addressing these mental health challenges. However, it remains crucial to strike a balance between their benefits and potential risks, including dependence and side effects, prompting a consideration of holistic approaches to mental health care. The evolving landscape of anxiety management underscores the importance of comprehensive strategies encompassing therapy, lifestyle adjustments, alternative medications, and careful, discerning use of benzodiazepines.

 

Market Driver- The aging population boom is fueling an increased demand for benzodiazepine drugs.

The surge in the aging population is a key factor driving the increased demand for benzodiazepine drugs. With advancing age, individuals often confront diverse health challenges, particularly in the realm of mental health, such as anxiety and insomnia. Given the sedative and anxiolytic properties of benzodiazepines, these medications are frequently prescribed to manage these conditions in the elderly. The global increase in life expectancy has resulted in a growing demographic of older adults who may grapple with age-related anxiety, sleep disturbances, or other neurological disorders, leading to a notable uptick in the need for benzodiazepine medications. This trend emphasizes the necessity for healthcare systems to adjust to the evolving healthcare needs of an aging population, ensuring appropriate accessibility to medications while mindful of potential risks associated with prolonged benzodiazepine use in this demographic.

 

 

Market Opportunity- Growing recognition of mental health issues is driving demand for Benzodiazepines as a treatment option

The increasing acknowledgment of mental health issues has generated a heightened demand for benzodiazepines as a treatment choice. Particularly, anxiety disorders are gaining broader recognition, prompting individuals to actively seek medical assistance. Benzodiazepines, recognized for their anxiolytic properties, are frequently recommended to alleviate symptoms linked to diverse anxiety disorders, including generalized anxiety disorder and panic disorder. Furthermore, the growing awareness of stress's impact on mental health contributes to the expanding utilization of benzodiazepines for short-term relief. It is crucial to emphasize that, despite their efficacy in symptom management, healthcare professionals meticulously assess the advantages against potential risks, such as dependence and withdrawal issues, before prescribing these medications. Simultaneously, the pharmaceutical industry is observing heightened research and development endeavors to devise alternative treatments and therapies addressing mental health concerns while mitigating the side effects and risks associated with benzodiazepines.

 

Market Share Analysis- Alprazolam Benzodiazepine Drugs Market will register the fastest growth

The Global Benzodiazepine Drugs Market is analyzed across Alprazolam, Diazepam, Lorazepam, Clonazepam, and others. Alprazolam is poised to register the fastest growth. Alprazolam, a benzodiazepine medication, is widely prescribed for anxiety and panic disorders, contributing to the benzodiazepine drugs market. Market dynamics are influenced by the prevalence of anxiety-related disorders, an aging population, and evolving trends in mental health treatment. Despite its effectiveness, concerns about dependence and withdrawal caution healthcare professionals in prescribing Alprazolam. The market's future may involve research into novel formulations, alternatives, and personalized medicine approaches, reflecting broader advancements in mental health awareness and treatment.

 

Market Share Analysis- Anxiety disorders held a significant market share in 2023

The Global Benzodiazepine Drugs Market is analyzed across various applications including Anxiety disorders, Seizures, Insomnia, Alcohol Withdrawal, and others. Of these, anxiety disorders held a significant market share in 2023. The growing prevalence and recognition of anxiety disorders are key drivers of the Benzodiazepine Drugs Market. Benzodiazepines, known for their anxiolytic properties, are widely prescribed to address conditions such as generalized anxiety disorder and panic disorder. The market's expansion is fueled by the increasing demand for effective pharmaceutical solutions for anxiety-related conditions. However, concerns about dependence and withdrawal risks necessitate a careful balance in their prescription. Ongoing research focuses on addressing these issues and exploring alternative treatments, while regulatory measures and advancements in mental health awareness further shape the market dynamics.

 

Benzodiazepine Drugs Market Segmentation

By Product

• Alprazolam
• Diazepam
• Lorazepam
• Clonazepam

 

 By Application

• Anxiety disorders
• Seizures
• Insomnia
• Alcohol Withdrawal

 

By Time of Action

• Ultra-short Acting
• Short Acting
• Long Acting

 

By Region    

• North America (United States, Canada, Mexico)
• Europe (Germany, France, United Kingdom, Spain, Italy, Others)
• Asia Pacific (China, India, Japan, South Korea, Australia, Others)
• Latin America (Brazil, Argentina, Others)
• Middle East and Africa (Saudi Arabia, UAE, Kuwait, Other Middle East, South Africa, Nigeria, Other Africa)

 

Benzodiazepine Drugs Market Companies

• Amneal Pharmaceuticals LLC
• Apotex Inc
• Aurobindo Pharma
• Bausch Health Companies Inc
• F.Hoffmann-La Roche Ltd
• H.Lundbeck A/S
• Mylan N.V
• Pfizer Inc
• Sun Pharmaceutical Industries Ltd
• Teva Pharmaceutical Industries Ltd

 

*List Not Exhaustive

Benzodiazepine Drugs Market Outlook 2023

1 Market Overview

1.1 Introduction to the Benzodiazepine Drugs Market

1.2 Scope of the Study

1.3 Research Objective

1.3.1 Key Market Scope and Segments

1.3.2 Players Covered

1.3.3 Years Considered

 

2 Executive Summary

2.1 2023 Benzodiazepine Drugs Industry- Market Statistics

3 Market Dynamics

3.1 Market Drivers

3.2 Market Challenges

3.3 Market Opportunities

3.4 Market Trends

 

4 Market Factor Analysis

4.1 Porter’s Five Forces

4.2 Market Entropy

4.2.1 Global Benzodiazepine Drugs Market Companies with Area Served

4.2.2 Products Offerings Global Benzodiazepine Drugs Market

 

5 COVID-19 Impact Analysis and Outlook Scenarios

5.1.1 Covid-19 Impact Analysis

5.1.2 post-COVID-19 Scenario- Low Growth Case

5.1.3 post-COVID-19 Scenario- Reference Growth Case

5.1.4 post-COVID-19 Scenario- Low Growth Case

 

6 Global Benzodiazepine Drugs Market Trends

6.1 Global Benzodiazepine Drugs Revenue (USD Million) and CAGR (%) by Type (2018-2030)

6.2 Global Benzodiazepine Drugs Revenue (USD Million) and CAGR (%) by Applications (2018-2030)

6.3 Global Benzodiazepine Drugs Revenue (USD Million) and CAGR (%) by regions (2018-2030)

 

7 Global Benzodiazepine Drugs Market Revenue (USD Million) by Type, and Applications (2018-2022)

7.1 Global Benzodiazepine Drugs Revenue (USD Million) by Type (2018-2022)

7.1.1 Global Benzodiazepine Drugs Revenue (USD Million), Market Share (%) by Type (2018-2022)

7.2 Global Benzodiazepine Drugs Revenue (USD Million) by Applications (2018-2022)

7.2.1 Global Benzodiazepine Drugs Revenue (USD Million), Market Share (%) by Applications (2018-2022)

 

8 Global Benzodiazepine Drugs Development Regional Status and Outlook

8.1 Global Benzodiazepine Drugs Revenue (USD Million) By Regions (2018-2022)

8.2 North America Benzodiazepine Drugs Revenue (USD Million) by Type, and Application (2018-2022)

8.2.1 North America Benzodiazepine Drugs Revenue (USD Million) by Country (2018-2022)

8.2.2 North America Benzodiazepine Drugs Revenue (USD Million) by Type (2018-2022)

8.2.3 North America Benzodiazepine Drugs Revenue (USD Million) by Applications (2018-2022)

8.3 Europe Benzodiazepine Drugs Revenue (USD Million), by Type, and Applications (USD Million) (2018-2022)

8.3.1 Europe Benzodiazepine Drugs Revenue (USD Million), by Country (2018-2022)

8.3.2 Europe Benzodiazepine Drugs Revenue (USD Million) by Type (2018-2022)

8.3.3 Europe Benzodiazepine Drugs Revenue (USD Million) by Applications (2018-2022)

8.4 Asia Pacific Benzodiazepine Drugs Revenue (USD Million), and Revenue (USD Million) by Type, and Applications (2018-2022)

8.4.1 Asia Pacific Benzodiazepine Drugs Revenue (USD Million) by Country (2018-2022)

8.4.2 Asia Pacific Benzodiazepine Drugs Revenue (USD Million) by Type (2018-2022)

8.4.3 Asia Pacific Benzodiazepine Drugs Revenue (USD Million) by Applications (2018-2022)

8.5 South America Benzodiazepine Drugs Revenue (USD Million), by Type, and Applications (2018-2022)

8.5.1 South America Benzodiazepine Drugs Revenue (USD Million), by Country (2018-2022)

8.5.2 South America Benzodiazepine Drugs Revenue (USD Million) by Type (2018-2022)

8.5.3 South America Benzodiazepine Drugs Revenue (USD Million) by Applications (2018-2022)

8.6 Middle East and Africa Benzodiazepine Drugs Revenue (USD Million), by Type, Technology, Application, Thickness (2018-2022)

8.6.1 Middle East and Africa Benzodiazepine Drugs Revenue (USD Million) by Country (2018-2022)

8.6.2 Middle East and Africa Benzodiazepine Drugs Revenue (USD Million) by Type (2018-2022)

8.6.3 Middle East and Africa Benzodiazepine Drugs Revenue (USD Million) by Applications (2018-2022)

 

9 Company Profiles

 

10 Global Benzodiazepine Drugs Market Revenue (USD Million), by Type, and Applications (2023-2030)

10.1 Global Benzodiazepine Drugs Revenue (USD Million) and Market Share (%) by Type (2023-2030)

10.1.1 Global Benzodiazepine Drugs Revenue (USD Million), and Market Share (%) by Type (2023-2030)

10.2 Global Benzodiazepine Drugs Revenue (USD Million) and Market Share (%) by Applications (2023-2030)

10.2.1 Global Benzodiazepine Drugs Revenue (USD Million), and Market Share (%) by Applications (2023-2030)

 

11 Global Benzodiazepine Drugs Development Regional Status and Outlook Forecast

11.1 Global Benzodiazepine Drugs Revenue (USD Million) By Regions (2023-2030)

11.2 North America Benzodiazepine Drugs Revenue (USD Million) by Type, and Applications (2023-2030)

11.2.1 North America Benzodiazepine Drugs Revenue (USD) Million by Country (2023-2030)

11.2.2 North America Benzodiazepine Drugs Revenue (USD Million), by Type (2023-2030)

11.2.3 North America Benzodiazepine Drugs Revenue (USD Million), Market Share (%) by Applications (2023-2030)

11.3 Europe Benzodiazepine Drugs Revenue (USD Million), by Type, and Applications (2023-2030)

11.3.1 Europe Benzodiazepine Drugs Revenue (USD Million), by Country (2023-2030)

11.3.2 Europe Benzodiazepine Drugs Revenue (USD Million), by Type (2023-2030)

11.3.3 Europe Benzodiazepine Drugs Revenue (USD Million), by Applications (2023-2030)

11.4 Asia Pacific Benzodiazepine Drugs Revenue (USD Million) by Type, and Applications (2023-2030)

11.4.1 Asia Pacific Benzodiazepine Drugs Revenue (USD Million), by Country (2023-2030)

11.4.2 Asia Pacific Benzodiazepine Drugs Revenue (USD Million), by Type (2023-2030)

11.4.3 Asia Pacific Benzodiazepine Drugs Revenue (USD Million), by Applications (2023-2030)

11.5 South America Benzodiazepine Drugs Revenue (USD Million), by Type, and Applications (2023-2030)

11.5.1 South America Benzodiazepine Drugs Revenue (USD Million), by Country (2023-2030)

11.5.2 South America Benzodiazepine Drugs Revenue (USD Million), by Type (2023-2030)

11.5.3 South America Benzodiazepine Drugs Revenue (USD Million), by Applications (2023-2030)

11.6 Middle East and Africa Benzodiazepine Drugs Revenue (USD Million), by Type, and Applications (2023-2030)

11.6.1 Middle East and Africa Benzodiazepine Drugs Revenue (USD Million), by region (2023-2030)

11.6.2 Middle East and Africa Benzodiazepine Drugs Revenue (USD Million), by Type (2023-2030)

11.6.3 Middle East and Africa Benzodiazepine Drugs Revenue (USD Million), by Applications (2023-2030)

 

12 Methodology and Data Sources

12.1 Methodology/Research Approach

12.1.1 Research Programs/Design

12.1.2 Market Size Estimation

12.1.3 Market Breakdown and Data Triangulation

12.2 Data Sources

12.2.1 Secondary Sources

12.2.2 Primary Sources

12.3 Disclaimer

 

List of Tables

Table 1 Market Segmentation Analysis

Table 2 Global Benzodiazepine Drugs Market Companies with Areas Served

Table 3 Products Offerings Global Benzodiazepine Drugs Market

Table 4 Low Growth Scenario Forecasts

Table 5 Reference Case Growth Scenario

Table 6 High Growth Case Scenario

Table 7 Global Benzodiazepine Drugs Revenue (USD Million) And CAGR (%) By Type (2018-2030)

Table 8 Global Benzodiazepine Drugs Revenue (USD Million) And CAGR (%) By Applications (2018-2030)

Table 9 Global Benzodiazepine Drugs Revenue (USD Million) And CAGR (%) By Regions (2018-2030)

Table 10 Global Benzodiazepine Drugs Revenue (USD Million) By Type (2018-2022)

Table 11 Global Benzodiazepine Drugs Revenue Market Share (%) By Type (2018-2022)

Table 12 Global Benzodiazepine Drugs Revenue (USD Million) By Applications (2018-2022)

Table 13 Global Benzodiazepine Drugs Revenue Market Share (%) By Applications (2018-2022)

Table 14 Global Benzodiazepine Drugs Market Revenue (USD Million) By Regions (2018-2022)

Table 15 Global Benzodiazepine Drugs Market Share (%) By Regions (2018-2022)

Table 16 North America Benzodiazepine Drugs Revenue (USD Million) By Country (2018-2022)

Table 17 North America Benzodiazepine Drugs Revenue (USD Million) By Type (2018-2022)

Table 18 North America Benzodiazepine Drugs Revenue (USD Million) By Applications (2018-2022)

Table 19 Europe Benzodiazepine Drugs Revenue (USD Million) By Country (2018-2022)

Table 20 Europe Benzodiazepine Drugs Revenue (USD Million) By Type (2018-2022)

Table 21 Europe Benzodiazepine Drugs Revenue (USD Million) By Applications (2018-2022)

Table 22 Asia Pacific Benzodiazepine Drugs Revenue (USD Million) By Country (2018-2022)

Table 23 Asia Pacific Benzodiazepine Drugs Revenue (USD Million) By Type (2018-2022)

Table 24 Asia Pacific Benzodiazepine Drugs Revenue (USD Million) By Applications (2018-2022)

Table 25 South America Benzodiazepine Drugs Revenue (USD Million) By Country (2018-2022)

Table 26 South America Benzodiazepine Drugs Revenue (USD Million) By Type (2018-2022)

Table 27 South America Benzodiazepine Drugs Revenue (USD Million) By Applications (2018-2022)

Table 28 Middle East and Africa Benzodiazepine Drugs Revenue (USD Million) By Region (2018-2022)

Table 29 Middle East and Africa Benzodiazepine Drugs Revenue (USD Million) By Type (2018-2022)

Table 30 Middle East and Africa Benzodiazepine Drugs Revenue (USD Million) By Applications (2018-2022)

Table 31 Financial Analysis

Table 32 Global Benzodiazepine Drugs Revenue (USD Million) By Type (2023-2030)

Table 33 Global Benzodiazepine Drugs Revenue Market Share (%) By Type (2023-2030)

Table 34 Global Benzodiazepine Drugs Revenue (USD Million) By Applications (2023-2030)

Table 35 Global Benzodiazepine Drugs Revenue Market Share (%) By Applications (2023-2030)

Table 36 Global Benzodiazepine Drugs Market Revenue (USD Million), And Revenue (USD Million) By Regions (2023-2030)

Table 37 North America Benzodiazepine Drugs Revenue (USD)By Country (2023-2030)

Table 38 North America Benzodiazepine Drugs Revenue (USD Million) By Type (2023-2030)

Table 39 North America Benzodiazepine Drugs Revenue (USD Million) By Applications (2023-2030)

Table 40 Europe Benzodiazepine Drugs Revenue (USD Million) By Country (2023-2030)

Table 41 Europe Benzodiazepine Drugs Revenue (USD Million) By Type (2023-2030)

Table 42 Europe Benzodiazepine Drugs Revenue (USD Million) By Applications (2023-2030)

Table 43 Asia Pacific Benzodiazepine Drugs Revenue (USD Million) By Country (2023-2030)

Table 44 Asia Pacific Benzodiazepine Drugs Revenue (USD Million) By Type (2023-2030)

Table 45 Asia Pacific Benzodiazepine Drugs Revenue (USD Million) By Applications (2023-2030)

Table 46 South America Benzodiazepine Drugs Revenue (USD Million) By Country (2023-2030)

Table 47 South America Benzodiazepine Drugs Revenue (USD Million) By Type (2023-2030)

Table 48 South America Benzodiazepine Drugs Revenue (USD Million) By Applications (2023-2030)

Table 49 Middle East and Africa Benzodiazepine Drugs Revenue (USD Million) By Region (2023-2030)

Table 50 Middle East and Africa Benzodiazepine Drugs Revenue (USD Million) By Region (2023-2030)

Table 51 Middle East and Africa Benzodiazepine Drugs Revenue (USD Million) By Type (2023-2030)

Table 52 Middle East and Africa Benzodiazepine Drugs Revenue (USD Million) By Applications (2023-2030)

Table 53 Research Programs/Design for This Report

Table 54 Key Data Information from Secondary Sources

Table 55 Key Data Information from Primary Sources

 

List of Figures

Figure 1 Market Scope

Figure 2 Porter’s Five Forces

Figure 3 Global Benzodiazepine Drugs Revenue (USD Million) By Type (2018-2022)

Figure 4 Global Benzodiazepine Drugs Revenue Market Share (%) By Type (2022)

Figure 5 Global Benzodiazepine Drugs Revenue (USD Million) By Applications (2018-2022)

Figure 6 Global Benzodiazepine Drugs Revenue Market Share (%) By Applications (2022)

Figure 7 Global Benzodiazepine Drugs Market Revenue (USD Million) By Regions (2018-2022)

Figure 8 Global Benzodiazepine Drugs Market Share (%) By Regions (2022)

Figure 9 North America Benzodiazepine Drugs Revenue (USD Million) By Country (2018-2022)

Figure 10 North America Benzodiazepine Drugs Revenue (USD Million) By Type (2018-2022)

Figure 11 North America Benzodiazepine Drugs Revenue (USD Million) By Applications (2018-2022)

Figure 12 Europe Benzodiazepine Drugs Revenue (USD Million) By Country (2018-2022)

Figure 13 Europe Benzodiazepine Drugs Revenue (USD Million) By Type (2018-2022)

Figure 14 Europe Benzodiazepine Drugs Revenue (USD Million) By Applications (2018-2022)

Figure 15 Asia Pacific Benzodiazepine Drugs Revenue (USD Million) By Country (2018-2022)

Figure 16 Asia Pacific Benzodiazepine Drugs Revenue (USD Million) By Type (2018-2022)

Figure 17 Asia Pacific Benzodiazepine Drugs Revenue (USD Million) By Applications (2018-2022)

Figure 18 South America Benzodiazepine Drugs Revenue (USD Million) By Country (2018-2022)

Figure 19 South America Benzodiazepine Drugs Revenue (USD Million) By Type (2018-2022)

Figure 20 South America Benzodiazepine Drugs Revenue (USD Million) By Applications (2018-2022)

Figure 21 Middle East and Africa Benzodiazepine Drugs Revenue (USD Million) By Region (2018-2022)

Figure 22 Middle East and Africa Benzodiazepine Drugs Revenue (USD Million) By Type (2018-2022)

Figure 23 Middle East and Africa Benzodiazepine Drugs Revenue (USD Million) By Applications (2018-2022)

Figure 24 Global Benzodiazepine Drugs Revenue (USD Million) By Type (2023-2030)

Figure 25 Global Benzodiazepine Drugs Revenue Market Share (%) By Type (2030)

Figure 26 Global Benzodiazepine Drugs Revenue (USD Million) By Applications (2023-2030)

Figure 27 Global Benzodiazepine Drugs Revenue Market Share (%) By Applications (2030)

Figure 28 Global Benzodiazepine Drugs Market Revenue (USD Million) By Regions (2023-2030)

Figure 29 North America Benzodiazepine Drugs Revenue (USD Million) By Country (2023-2030)

Figure 30 North America Benzodiazepine Drugs Revenue (USD Million) By Type (2023-2030)

Figure 31 North America Benzodiazepine Drugs Revenue (USD Million) By Applications (2023-2030)

Figure 32 Europe Benzodiazepine Drugs Revenue (USD Million) By Country (2023-2030)

Figure 33 Europe Benzodiazepine Drugs Revenue (USD Million) By Type (2023-2030)

Figure 34 Europe Benzodiazepine Drugs Revenue (USD Million) By Applications (2023-2030)

Figure 35 Asia Pacific Benzodiazepine Drugs Revenue (USD Million) By Country (2023-2030)

Figure 36 Asia Pacific Benzodiazepine Drugs Revenue (USD Million) By Type (2023-2030)

Figure 37 Asia Pacific Benzodiazepine Drugs Revenue (USD Million) By Applications (2023-2030)

Figure 38 South America Benzodiazepine Drugs Revenue (USD Million) By Country (2023-2030)

Figure 39 South America Benzodiazepine Drugs Revenue (USD Million) By Type (2023-2030)

Figure 40 South America Benzodiazepine Drugs Revenue (USD Million) By Applications (2023-2030)

Figure 41 Middle East and Africa Benzodiazepine Drugs Revenue (USD Million) By Region (2023-2030)

Figure 42 Middle East and Africa Benzodiazepine Drugs Revenue (USD Million) By Region (2023-2030)

Figure 43 Middle East and Africa Benzodiazepine Drugs Revenue (USD Million) By Type (2023-2030)

Figure 44 Middle East and Africa Benzodiazepine Drugs Revenue (USD Million) By Applications (2023-2030)

Figure 45 Bottom-Up and Top-Down Approaches for This Report

Figure 46 Data Triangulation

 

Benzodiazepine Drugs Market Segmentation

By Product

• Alprazolam
• Diazepam
• Lorazepam
• Clonazepam

 

 By Application

• Anxiety disorders
• Seizures
• Insomnia
• Alcohol Withdrawal

 

By Time of Action

• Ultra-short Acting
• Short Acting
• Long Acting

 

By Region    

• North America (United States, Canada, Mexico)
• Europe (Germany, France, United Kingdom, Spain, Italy, Others)
• Asia Pacific (China, India, Japan, South Korea, Australia, Others)
• Latin America (Brazil, Argentina, Others)
• Middle East and Africa (Saudi Arabia, UAE, Kuwait, Other Middle East, South Africa, Nigeria, Other Africa)